XML 56 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Options and Warrants (Tables)
6 Months Ended 12 Months Ended
Aug. 31, 2020
Feb. 29, 2020
Equity-based Compensation and Warrants    
Schedule of stock-based compensation

    

2019

    

2020

     

2019

    

2020

Cost of revenue

$

103

$

218

$

175

$

327

Product and technology

 

491

 

718

 

852

 

1,152

Sales and marketing

 

475

 

490

 

822

 

792

General and administrative

 

826

 

679

 

1,482

 

1,093

Total stock-based compensation

$

1,895

$

2,105

$

3,331

$

3,364

Fiscal year

2019

2020

Cost of revenue

    

$

255

    

$

318

Product and technology

 

1,108

 

1,674

Sales and marketing

 

1,199

 

1,482

General and administrative

 

3,159

 

2,528

Total stock‑based compensation

$

5,721

$

6,002

Schedule of weighted average assumptions  

Fiscal year

 

    

2019

    

2020

 

Estimated fair value of common stock

    

$

2.40

-

$

3.35

    

$

4.80

-

$

9.55

Exercise price

$

4.70

-

$

6.75

$

9.60

-

$

18.70

Expected volatility

46

%  

-

50

%  

50

%

Expected term (in years)

6.25

6.25

Risk‑free interest rate

2.65

%  

-

2.94

%  

1.67

%  

-

2.62

%

Dividend yield

Schedule of stock option activity

    

    

Weighted 

    

Weighted 

    

average 

remaining 

Aggregate 

exercise

contractual life

 

intrinsic

 

Stock Options

  price

  in years

value

Balance, February 29, 2020

 

7,996,056

 

$

6.19

 

Granted

 

2,149,575

 

17.25

 

  

 

  

Exercised

 

(571,382)

 

4.42

 

  

 

  

Forfeited

 

(147,684)

 

6.12

 

  

 

  

Balance, August 31, 2020

 

9,426,565

 

$

8.82

 

7.4

years  

$

223,660

Vested and expected to vest as of August 31, 2020

9,426,565

$

8.82

7.4

years  

$

223,660

Exercisable as of August 31, 2020

 

5,499,412

$

6.19

 

6.3

years  

$

150,792

    

    

    

Weighted

    

Weighted

Remaining

Aggregate

Average

Contractual

Intrinsic

Stock Options

Exercise Price

Life In Years

Value

Balance, February 28, 2018

 

6,970,591

 

  

 

  

 

  

Granted

 

1,635,115

 

  

 

  

 

  

Exercised

 

(249,027)

 

  

 

  

 

  

Forfeited

 

(209,135)

 

  

 

  

 

  

Balance, February 28, 2019

 

8,147,544

 

  

 

  

 

  

Granted

 

2,084,046

$

10.80

 

  

 

  

Exercised

 

(1,843,001)

$

3.70

 

  

 

  

Forfeited

 

(392,533)

$

5.70

 

  

 

  

Balance, February 29, 2020

 

7,996,056

$

6.19

 

7.0

years  

$

73,631

Vested and expected to vest as of February 29, 2020

 

7,996,056

$

6.20

 

7.0

years  

$

73,631

Exercisable as of February 29, 2020

 

4,579,458

$

4.35

 

5.6

years  

$

50,573

Schedule of warrants

    

Common Stock

Warrants

Balance, February 29, 2020

 

1,653,268

Issued

 

Exercised

 

(160,000)

Automatic exercise of warrants in connection with IPO

(1,493,268)

Balance, August 31, 2020

 

    

Common Stock

    

    

Exercise

    

Expiration

Warrants

Exercisable

Price

Date

Balance, February 28, 2018

 

928,945

 

  

 

  

 

  

Issued

 

541,159

 

  

 

  

 

  

Exercised

 

(4,061)

 

  

 

  

 

  

Balance, February 28, 2019

 

1,466,043

 

  

 

  

 

  

Issued

 

220,594

 

  

 

  

 

  

Exercised

 

(33,369)

 

  

 

  

 

  

Balance, February 29, 2020

 

1,653,268

 

1,653,268

$

0.0005

-

$

23.75

 

April 2020 - October 2029

Number of Warrants

Outstanding at

February 28/29,

Exercise

2019

2020

Price

Expiration Date

Series E holders

    

1,162,483

    

1,129,114

    

$

0.0005

    

July 2026 - March 2028

Series F holders

 

 

85,000

$

0.0005

 

October 2029

Customer

 

160,000

 

160,000

$

13.75

 

April 2020

Lenders

 

143,560

 

279,154

$

0.005

-

$

23.75

 

Nov 2022 - July 2029

Total

 

1,466,043

 

1,653,268